Gambro Group

Gambro Group, based in Sweden, is a healthcare company specializing in renal care solutions, providing medical devices and therapies to enhance patient treatment across diverse healthcare settings. Founded in 1964 in Lund, Sweden, Gambro Group focuses on renal care and operates globally with a significant presence in healthcare technology. In December 2012, Baxter International Inc. acquired the company for SEK 26.

5 billion (approximately USD 4 billion) from EQT and Investor AB. The acquisition was strategic, allowing Baxter to expand its portfolio of renal products and therapies. Gambro Group, through Baxter, offers an extensive range of medical products, including dialysis equipment and therapies specifically designed for renal care. Their portfolio enhances patient treatment options across various healthcare environments, including hospitals and outpatient settings.

The company caters to healthcare providers with advanced solutions aimed at addressing chronic kidney disease and other health challenges, leveraging innovative medical technologies. In the most recent fiscal year, Gambro Group reported a revenue of SEK 1,848,000,000. The company utilizes a diverse revenue model, engaging in both Business-to-Business (B2B) and direct-to-consumer transactions, ensuring comprehensive service delivery in the healthcare sector. Gambro Group's future growth strategy includes the continued development of new renal products and therapies to address emerging healthcare needs.

The company plans to expand its market reach significantly in Europe and Asia by 2025, leveraging the recent acquisition funding of SEK 26. 5 billion (approximately USD 4 billion) from Baxter International Inc. This financial backing will support the launch of innovative medical solutions and enhance operational capabilities to meet the evolving demands of healthcare providers.